PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets for facial scan that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia and pre-verbal infants. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.025790513163342178 | N/A |
Market Cap | $37.03M | N/A |
Shares Outstanding | 1.44B | 27.26% |
Employees | 0 | N/A |
Shareholder Equity | 668.13K | -86.15% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 27.99 | N/A |
P/B Ratio | 55.43 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -7.6945 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $1.32M | N/A |
Earnings | -$5.14M | N/A |
Gross Margin | 0.3655 | N/A |
Operating Margin | -4.50 | N/A |
Net income margin | -3.89 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $1.90M | N/A |
Cash on Hand | $1.71M | N/A |
Debt to Equity | $2.16 | 739.61% |
Current Ratio | $1.30 | -64.03% |